11.81
price down icon2.48%   -0.29
 
loading

Finanzdaten der Dyne Therapeutics Inc-Aktie (DYN)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
2.17%
69.16
67.69 62.27 66.74 45.46
Operating Income/Loss
2.17%
-69.16
-67.69 -62.27 -66.74 -45.46
Income/Loss From Continuing Operations Before Tax
1.48%
-65.65
-66.64 -60.21 -64.90 -44.19
Income/Loss From Continuing Operations After Tax
1.48%
-65.65
-66.64 -60.21 -64.90 -44.19
Net Income/Loss
1.48%
-65.65
-66.64 -60.21 -64.90 -44.19
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Earnings Per Share
25.69%
-0.81
-1.09 -0.99 -1.08 -0.78
Diluted Earnings Per Share
25.69%
-0.81
-1.09 -0.99 -1.08 -0.78
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$65.83
price up icon 0.30%
$19.61
price up icon 1.76%
$32.88
price up icon 0.37%
$24.21
price down icon 0.81%
$94.70
price up icon 0.32%
biotechnology ONC
$223.89
price down icon 0.44%
Kapitalisierung:     |  Volumen (24h):